Axonics Modulation Technologies Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Axonics Modulation prevailing Real Value cannot be determined due to lack of data. The current price of Axonics Modulation is $0.0. Our model approximates the value of Axonics Modulation from analyzing the firm fundamentals such as Current Valuation of 3.32 B, profit margin of (0.01) %, and Return On Equity of -0.0089 as well as examining its technical indicators and probability of bankruptcy.
Axonics Modulation Total Value Analysis
Axonics Modulation Technologies is presently estimated to have valuation of 3.32 B with market capitalization of 3.63 B, debt of 27.62 M, and cash on hands of 213.23 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Axonics Modulation fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.32 B | 3.63 B | 27.62 M | 213.23 M |
Axonics Modulation Investor Information
About 87.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.1. Axonics Modulation had not issued any dividends in recent years. Based on the analysis of Axonics Modulation's profitability, liquidity, and operating efficiency, Axonics Modulation Technologies is not in a good financial situation at the moment. It has a very high risk of going through financial straits in August.Axonics Modulation Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Axonics suggests not a very effective usage of assets in July.Axonics Modulation Ownership Allocation
Axonics Modulation holds a total of 51.11 Million outstanding shares. The majority of Axonics Modulation Technologies outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Axonics Modulation to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Axonics Modulation. Please pay attention to any change in the institutional holdings of Axonics Modulation Technologies as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Axonics Modulation Profitability Analysis
The company reported the previous year's revenue of 366.38 M. Net Loss for the year was (6.09 M) with profit before overhead, payroll, taxes, and interest of 197.66 M.Axonics Modulation Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 49.1 M | |
| Quarterly Earnings Growth Y O Y | 8.448 | |
| Forward Price Earnings | 106.383 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in Axonics Stock
If you are still planning to invest in Axonics Modulation check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Axonics Modulation's history and understand the potential risks before investing.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |